India to Export Covid-19 Vaccines in a Few Weeks
Recently, emergency use approval to Serum Institute’s Covishield and Bharat BioTech’s Covaxin, the two highly-awaited coronavirus vaccines was given. A report stating a ban on exporting these locally-made coronavirus vaccines was doing rounds. A Foreign Ministry official dismissed the report stating that the country plans to commence the export of Covishield and Covaxin within a fortnight of their launch.
It is to be noted that India makes about 60% of vaccines on a global level. While many countries await for the shipping to begin, India’s plans to help its neighbours are on.
As per the Foreign Ministry official, "Export of Covid-19 vaccines will be allowed to some of the South Asian neighbours within a fortnight of the rollout. While some of the exports will be given by the country in the form of gifts, others will be supplied at approximately the same price India will be purchasing the vaccines at.” Further, he added, “India, as the world’s biggest vaccine maker is highly aware of its commitments to neighbouring countries and the rest of the world.”
Rajesh Bhushan, Federal Health Secretary confirmed that the Indian government plans to roll out the novel coronavirus vaccines by the middle of January. He confirmed that coronavirus vaccine roll-out will begin in 10 days’ time, counting from the Emergency Use Authorisation date.”
A combined stock of more than 70 million doses of the coronavirus disease vaccines has been prepared by Serum Institute and Bharat Biotech. Both the companies are to scale up production on a magnificent level to meet the rising demand of covid vaccines in the coming time.
On Tuesday, a joint statement confirming “global access for Covid-19 vaccines” was released by Serum Institute and Bharat Biotech.
You May Like To Read: How Mild COVID-19 Symptoms Can Quickly Become Serious?
Disclaimer: This article is issued in the general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.
